Population
Strain A22 Iraq 24/64 of foot-and-mouth disease virus
Design
Preclinical
Authors
Loading...
May guide FMDV antigen design; hypothesis-generating in animal models without translation to livestock.
Synthetic peptides representing the major antigenic site on VP1 elicit broad cross-neutralizing antibodies against foot-and-mouth disease virus.
Bolwell et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: